Saturday, July 13, 2024

Roche Launches New Units for cobas® pro Solutions

Similar articles

Roche has announced the launch of its new analytical units, cobas® c 703 and cobas® ISE neo, for the cobas® pro integrated solutions in countries accepting the CE mark. These units are designed to deliver higher testing capacity and increased automation, addressing key challenges faced by diagnostic laboratories such as staff shortages and space limitations. The cobas c 703 unit offers up to 2,000 tests per hour and 70 reagent positions, doubling the throughput of existing cobas pro solutions. The cobas ISE neo unit provides efficient ISE testing with up to 1,800 tests per hour, reducing hands-on time through automated maintenance.

Matt Sause, CEO of Roche Diagnostics, emphasized the importance of accurate and timely diagnostics in healthcare delivery. “Labs are under increasing pressure to process more samples at greater speed without compromising accuracy,” he said. “With the launch of the cobas c 703 and cobas ISE neo, we are setting a new standard for high-volume testing in clinical labs.” These units integrate high-volume clinical chemistry testing and automation, enhancing laboratory workflows and advancing patient care.

The cobas c 703 unit is designed to double the clinical chemistry throughput on cobas pro integrated solutions, offering up to 2,000 tests per hour with 70 reagent positions. This increased capacity allows more high-value tests to be performed, improving workflow efficiency and reducing time spent reloading reagents. Additionally, the unit minimizes operator maintenance to once a month, increasing uptime for laboratories and enhancing overall efficiency.

The cobas ISE neo unit improves ion selective electrode (ISE) testing efficiency, offering up to 1,800 tests per hour. Innovative hardware and software features, such as an automated calibration concept, significantly reduce the need for manual intervention. The unit performs more tests per reagent bottle, minimizing plastic waste and reducing logistical efforts compared to previous generation systems. This automation further improves lab efficiency, addressing staff shortages and increasing the volume of tests delivered to patients.

About cobas pro Integrated Solutions

Launched in 2018, cobas pro integrated solutions is a scalable and modular platform designed for mid-to-very-high volume clinical chemistry and immunochemistry testing. It increases efficiency with fast analytical units, intelligent sample routing, and short assay incubation times, with 93% of Roche immunoassays having reaction times of 18 minutes or less. The system features automated maintenance and cobas® AutoCal, an automated calibration procedure, to save hands-on time. Additionally, it incorporates cobas® SonicWash, an ultrasonic probe cleaning to ensure sample integrity.

cobas pro integrated solutions provide fully standardized results and operation, using the same reagents and assay menu as cobas® pure integrated solutions. This standardization allows for flexible staff assignment and minimal training needs, making the systems ideal for integrated health networks and lab chains. The platform is fully compatible with the cobas® mobile solution, a tablet that integrates multiple Roche applications, allowing laboratory professionals to interact with the analyzer from anywhere in the lab.

With cobas pro integrated solutions, the required sample volume per test has been reduced by 43% on average compared to previous generation systems. Additionally, the plastic generated per test result has been reduced by up to 78% due to smaller reagent pack sizes and a higher number of tests per pack. Designed to seamlessly integrate into clinical chemistry and immunochemistry testing, Roche’s innovative mass spectrometry analyzer will also be available as part of the cobas pro integrated solutions in the near future.

phase

Efficiency and Sustainability

The new analytical units from Roche are set to revolutionize laboratory workflows by enhancing efficiency and sustainability. The cobas c 703 and cobas ISE neo units automate many processes that were previously manual, reducing the burden on laboratory staff and allowing for faster, more reliable testing. This automation addresses the global shortage of qualified laboratory personnel and helps laboratories maximize their testing capabilities.

You can follow our news on our Telegram and LinkedIn accounts.

Roche’s commitment to sustainability is evident in the design of these new units. By reducing the required sample volume and the plastic waste generated per test, the cobas pro integrated solutions not only improve efficiency but also contribute to environmental sustainability. These advancements align with Roche’s broader goals of improving healthcare delivery and patient outcomes while minimizing the environmental impact of its operations.

The launch of the cobas c 703 and cobas ISE neo analytical units represents a significant advancement in laboratory diagnostics. These units enhance the capabilities of the cobas pro integrated solutions, providing high-volume, automated testing that improves laboratory efficiency and patient care. Roche continues to lead in diagnostic innovation, addressing the needs of modern laboratories and contributing to better health outcomes worldwide.

 

Resource: Roche, June 24, 2024

Subscribe to our newsletter

To be updated with all the latest news, offers and special announcements.

Latest article